title: Evidence for nuclear phosphoinositidase C activity in the antiproliferative signals produced by interferon in Burkitt lymphoma cells.
abstract: The influence of interferon alpha on nuclear phosphoinositidase C (PIC) in Daudi cells has been analysed. Results showed an early increase of PIC activity detectable within 90 min of interferon treatment concomitant with an increase of diacylglcerol (DAG) levels. Since the interferon-induced DAG production is not modified by the addition of propranolol, a compound known to inhibit production of DAG from phosphatidylcholine hydrolysis, it is suggested that the interferon antiproliferative signal is transduced into the nucleus via the inositol lipid pathway. A parallel analysis performed on intact cells showed a rapid inhibition of PIC activity accompanied by an increase of DAG level thus suggesting that interferon-generated signals at plasma-membrane level use pathways different from that of inositol lipids. A selected clone of Daudi cells resistant to interferon action provided a control for specificity of results.
authors.affiliation: Istituto di Morfologia Umana Normale, Università di Chieti, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Cataldi
authors.forename: R
authors.initials: R
authors.lastname: Rana
authors.forename: R
authors.initials: R
authors.lastname: Bareggi
authors.forename: R
authors.initials: R
authors.lastname: Lisio
authors.forename: I
authors.initials: I
authors.lastname: Robuffo
authors.forename: V
authors.initials: V
authors.lastname: di Valerio
authors.forename: S
authors.initials: S
authors.lastname: Miscia
mesh_terms: D002051:Burkitt Lymphoma / Q000201:enzymology* / Q000473:pathology*; D002118:Calcium / Q000494:pharmacology; D002460:Cell Line; D002467:Cell Nucleus / Q000187:drug effects / Q000201:enzymology* / Q000648:ultrastructure*; D004351:Drug Resistance; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000494:pharmacology*; D007700:Kinetics; D008854:Microscopy, Electron; D019269:Phosphatidylinositol 4,5-Diphosphate; D018129:Phosphatidylinositol Phosphates / Q000378:metabolism; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism*; D011433:Propranolol / Q000494:pharmacology; D011994:Recombinant Proteins; D014407:Tumor Cells, Cultured
chemical_list: D000077190:Interferon alpha-2; D016898:Interferon-alpha; D019269:Phosphatidylinositol 4,5-Diphosphate; D018129:Phosphatidylinositol Phosphates; D011994:Recombinant Proteins; D011433:Propranolol; D010727:Phosphoric Diester Hydrolases; C021491:glycerophosphoinositol glycerophosphodiesterase; D002118:Calcium